top of page
it's where dermatology lives
Secukinumab shows positive effects in HS at 52 weeks
Patients with moderate to severe hidradenitis suppurativa (HS) treated with secukinumab demonstrate sustained efficacy and symptom...
Allan Ryan
Feb 6, 20232 min read
Psoriasis biologic clinical trial findings confirmed by study of real-world data
A study of real-world data has shown that the relative difference in efficacy of secukinumab compared to ustekinumab used for psoriasis...
John Evans
Dec 11, 20202 min read
Featured Posts
bottom of page